论文标题
基于胸部射线照相的COVID-19诊断
Diagnosis of COVID-19 based on Chest Radiography
论文作者
论文摘要
2019年冠状病毒疾病(Covid-19)于2019年12月上旬在中国武汉发现,现在成为大流行。当Covid-19患者接受放射学检查检查时,放射科医生可以观察到其胸部X射线(CXR)图像的放射线异常。在这项研究中,提出了一个深卷卷神经网络(CNN)模型,以帮助放射科医生诊断COVID-19患者。首先,这项工作对修改的VGG-16,Resnet-50和Densenet-121的性能进行了比较研究,以将CXR图像分类为正常,Covid-19和病毒性肺炎。然后,评估了图像增强对分类结果的影响。在整个研究中,都使用了公开可用的COVID-19-19S射线照相数据库。比较后,Resnet-50以95.88%的速度达到了最高精度。接下来,在训练Resnet-50以旋转,翻译,水平翻转,强度偏移和变焦增强数据集后,精度降至80.95%。此外,一项关于图像增强对分类结果影响的消融研究发现,旋转和强度移动增强方法的组合获得的精度高于基线,即96.14%。最后,具有旋转和强度偏移增强的重新连接50表现最好,并被提出为这项工作的最终分类模型。这些发现表明,所提出的分类模型可以为Covid-19诊断提供有希望的结果。
The Coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China, in early December 2019 and now becoming a pandemic. When COVID-19 patients undergo radiography examination, radiologists can observe the present of radiographic abnormalities from their chest X-ray (CXR) images. In this study, a deep convolutional neural network (CNN) model was proposed to aid radiologists in diagnosing COVID-19 patients. First, this work conducted a comparative study on the performance of modified VGG-16, ResNet-50 and DenseNet-121 to classify CXR images into normal, COVID-19 and viral pneumonia. Then, the impact of image augmentation on the classification results was evaluated. The publicly available COVID-19 Radiography Database was used throughout this study. After comparison, ResNet-50 achieved the highest accuracy with 95.88%. Next, after training ResNet-50 with rotation, translation, horizontal flip, intensity shift and zoom augmented dataset, the accuracy dropped to 80.95%. Furthermore, an ablation study on the effect of image augmentation on the classification results found that the combinations of rotation and intensity shift augmentation methods obtained an accuracy higher than baseline, which is 96.14%. Finally, ResNet-50 with rotation and intensity shift augmentations performed the best and was proposed as the final classification model in this work. These findings demonstrated that the proposed classification model can provide a promising result for COVID-19 diagnosis.